Sodium‐glucose co‐transporter 2 inhibitors and the risk of fractures: A propensity score‐matched cohort study von Adimadhyam, Sruthi, Lee, Todd A., Calip, Gregory S., Smith Marsh, Daphne E., Layden, Brian T., Schumock, Glen T.

Volltext

Risk of amputations associated with SGLT2 inhibitors compared to DPP‐4 inhibitors: A propensity‐matched cohort study von Adimadhyam, Sruthi, Lee, Todd A., Calip, Gregory S., Smith Marsh, Daphne E., Layden, Brian T., Schumock, Glen T.

Volltext

Increased risk of mycotic infections associated with sodium–glucose co‐transporter 2 inhibitors: a prescription sequence symmetry analysis von Adimadhyam, Sruthi, Schumock, Glen T., Calip, Gregory S., Smith Marsh, Daphne E., Layden, Brian T., Lee, Todd A.

Volltext

Mobile Health Intervention in Patients With Type 2 Diabetes: A Randomized Clinical Trial von Gerber, Ben S., Biggers, Alana, Tilton, Jessica J., Smith Marsh, Daphne E., Lane, Rachel, Mihailescu, Dan, Lee, JungAe, Sharp, Lisa K.

Volltext

Managing adverse events related to SGLT2 inhibitors: what a pharmacist needs to know to optimize clinical outcomes von Smith, Daphne E

Volltext

Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance von Smith-Marsh, D

Volltext